Literature DB >> 33732871

A combinatorial library of biodegradable polyesters enables non-viral gene delivery to post-mitotic human stem cell-derived polarized RPE monolayers.

Bibhudatta Mishra1, David R Wilson2,3,4, Srinivas R Sripathi1, Mark P Suprenant2,3, Yuan Rui1,2,3, Karl J Wahlin1, Cynthia A Berlinicke1, Jordan J Green1,2,3,4,5,6,7, Donald J Zack4,8,9,8,10.   

Abstract

Safe and effective delivery of DNA to post-mitotic cells, especially highly differentiated cells, remains a challenge despite significant progress in the development of gene delivery tools. Biodegradable polymeric nanoparticles (NPs) offer an array of advantages for gene delivery over viral vectors due to improved safety, carrying capacity, ease of manufacture, and cell-type specificity. Here we demonstrate the use of a high-throughput screening (HTS) platform to synthesize and screen a library of 148 biodegradable polymeric nanoparticles, successfully identifying structures that enable efficient transfection of human pluripotent stem cell differentiated human retinal pigment epithelial (RPE) cells with minimal toxicity. These NPs can deliver plasmid DNA (pDNA) to RPE monolayers more efficiently than leading commercially available transfection reagents. Novel synthetic polymers are described that enable high efficacy non-viral gene delivery to hard-to-transfect polarized human RPE monolayers, enabling gene loss- and gain-of-function studies of cell signaling, developmental, and disease-related pathways. One new synthetic polymer in particular, 3,3'-iminobis(N,N-dimethylpropylamine)-end terminated poly(1,5-pentanediol diacrylate-co-3 amino-1-propanol) (5-3-J12), was found to form self-assembled nanoparticles when mixed with plasmid DNA that transfect a majority of these human post-mitotic cells with minimal cytotoxicity. The platform described here can be utilized as an enabling technology for gene transfer to human primary and stem cell-derived cells, which are often fragile and resistant to conventional gene transfer approaches.

Entities:  

Keywords:  Retinal pigment epithelial cell; human stem cell; nanoparticles; non-viral gene therapy; ophthalmology; poly(beta-amino ester); polymer

Year:  2019        PMID: 33732871      PMCID: PMC7962803          DOI: 10.1007/s40883-019-00118-1

Source DB:  PubMed          Journal:  Regen Eng Transl Med        ISSN: 2364-4141


  57 in total

Review 1.  The AAV vector toolkit: poised at the clinical crossroads.

Authors:  Aravind Asokan; David V Schaffer; R Jude Samulski
Journal:  Mol Ther       Date:  2012-01-24       Impact factor: 11.454

Review 2.  Intracellular trafficking of plasmids for gene therapy: mechanisms of cytoplasmic movement and nuclear import.

Authors:  Erin E Vaughan; James V DeGiulio; David A Dean
Journal:  Curr Gene Ther       Date:  2006-12       Impact factor: 4.391

Review 3.  Non-viral strategies for ocular gene delivery.

Authors:  Ana V Oliveira; Ana M Rosa da Costa; Gabriela A Silva
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2017-04-18       Impact factor: 7.328

Review 4.  Engineering adeno-associated viruses for clinical gene therapy.

Authors:  Melissa A Kotterman; David V Schaffer
Journal:  Nat Rev Genet       Date:  2014-05-20       Impact factor: 53.242

5.  Rapid optimization of gene delivery by parallel end-modification of poly(beta-amino ester)s.

Authors:  Gregory T Zugates; Weidan Peng; Andreas Zumbuehl; Siddharth Jhunjhunwala; Yu-Hung Huang; Robert Langer; Janet A Sawicki; Daniel G Anderson
Journal:  Mol Ther       Date:  2007-03-20       Impact factor: 11.454

6.  Quantification of cellular and nuclear uptake rates of polymeric gene delivery nanoparticles and DNA plasmids via flow cytometry.

Authors:  Corey J Bishop; Rebecca L Majewski; Toni-Rose M Guiriba; David R Wilson; Nupura S Bhise; Alfredo Quiñones-Hinojosa; Jordan J Green
Journal:  Acta Biomater       Date:  2016-03-24       Impact factor: 8.947

7.  Non-viral gene delivery nanoparticles based on poly(β-amino esters) for treatment of glioblastoma.

Authors:  Stephany Y Tzeng; Hugo Guerrero-Cázares; Elliott E Martinez; Joel C Sunshine; Alfredo Quiñones-Hinojosa; Jordan J Green
Journal:  Biomaterials       Date:  2011-05-04       Impact factor: 12.479

8.  Nano chitosan peptide as a potential therapeutic carrier for retinal delivery to treat age-related macular degeneration.

Authors:  Melamangalam S Jayaraman; Dhruba J Bharali; Thangirala Sudha; Shaker A Mousa
Journal:  Mol Vis       Date:  2012-09-03       Impact factor: 2.367

9.  Bioreducible cationic polymer-based nanoparticles for efficient and environmentally triggered cytoplasmic siRNA delivery to primary human brain cancer cells.

Authors:  Kristen L Kozielski; Stephany Y Tzeng; Bolivia A Hurtado De Mendoza; Jordan J Green
Journal:  ACS Nano       Date:  2014-04-03       Impact factor: 15.881

10.  Effects of Circular DNA Length on Transfection Efficiency by Electroporation into HeLa Cells.

Authors:  Benjamin D Hornstein; Dany Roman; Lirio M Arévalo-Soliz; Melinda A Engevik; Lynn Zechiedrich
Journal:  PLoS One       Date:  2016-12-05       Impact factor: 3.240

View more
  3 in total

1.  High-throughput and high-content bioassay enables tuning of polyester nanoparticles for cellular uptake, endosomal escape, and systemic in vivo delivery of mRNA.

Authors:  Yuan Rui; David R Wilson; Stephany Y Tzeng; Hannah M Yamagata; Deepti Sudhakar; Marranne Conge; Cynthia A Berlinicke; Donald J Zack; Anthony Tuesca; Jordan J Green
Journal:  Sci Adv       Date:  2022-01-05       Impact factor: 14.136

2.  Poly(Beta-Amino Ester)s as High-Yield Transfection Reagents for Recombinant Protein Production.

Authors:  Kathryn M Luly; Huilin Yang; Stephen J Lee; Wentao Wang; Seth D Ludwig; Haley E Tarbox; David R Wilson; Jordan J Green; Jamie B Spangler
Journal:  Int J Nanomedicine       Date:  2022-09-23

Review 3.  Automation and data-driven design of polymer therapeutics.

Authors:  Rahul Upadhya; Shashank Kosuri; Matthew Tamasi; Travis A Meyer; Supriya Atta; Michael A Webb; Adam J Gormley
Journal:  Adv Drug Deliv Rev       Date:  2020-11-24       Impact factor: 15.470

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.